Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-6756

ABSTRACT: Total RNA-seq of human oesophageal adenocarcinoma cell line OE19 treated with siNT, siHNF4A, siGATA6 and siHNF4A+siGATA6 for 72 hours

PROVIDER: E-MTAB-6756 | ExpressionAtlas | 2025-01-23

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-6756-analysis-methods.tsv	Tabular
	E-MTAB-6756-analytics.tsv	Tabular
	E-MTAB-6756-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-6756-configuration.xml	Xml
	E-MTAB-6756-g1_g2-mvaPlot.png	Other

Items per page:

1 - 5 of 45

Similar Datasets

Total RNA-seq of human oesophageal adenocarcinoma cell line OE19 treated with siNT, siHNF4A, siGATA6 and siHNF4A+siGATA6 for 72 hours

Project description:Total RNA-seq of human oesophageal adenocarcinoma cell line OE19 treated with siNT, siHNF4A, siGATA6 and siHNF4A+siGATA6 for 72 hours

| PRJEB26561 | ENA

Proteome alterations in MLL-rearranged leukemia cells following WIN Site inhibition

Project description:WIN Site inhibitors bind the WIN Site of WDR5 resulting in decreased transcription of WDR5 target genes, many of which encode components of the protein synthesis machinery. In this study, we determined proteome alterations in an MLL-rearranged leukemia cell line treated for either 24 or 72 hours with a WIN Site inhibitor. The data from these studies, along with Ribo-Seq, RNA-Seq, and CRISPR screen experiments, guided us in assembling a collection of compounds that, when combined with WIN Site inhibitor, synergistically inhibit growth of MLL-rearranged leukemia cells.

2023-07-04 | PXD035129 | Pride

Gene expression in Vemurafenib-treated A375 and A2058 melanoma cell lines

Project description:Human melanoma cell line A375 and A2058 were incubated with DMSO (control group) or Vemurafenib (1 μM in DMSO) for 72 hours. Total RNA was isolated with Qiagen RNA isolation kit; 1.5 μg of total RNA was used as template for cDNA synthesis.

2015-12-02 | GSE52882 | GEO

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma [ChIP-seq]

2014-07-20 | GSE59496 | GEO

Pan-cancer analysis of pyrimidine metabolism using pathway-based approach unravels complex signaling pathways connections with a role in chemoresistance

Project description:To investigate the effect of DHODH inhibitor, Brequinar (BRQ), in inhibiting the pyrimidine metabolism and its associated signaling pathways, lung cancer cell line (A549) was treated with BRQ for 72 hours and performed gene expression profiling using RNA-seq.

2023-12-04 | GSE248686 | GEO

RNA-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib

Project description:RNA-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib

| PRJEB44079 | ENA

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma [ChIP-seq]

Project description:ChIP-Seq analysis of a pediatric human diffuse intrinsic pontine glioma (DIPG) cell line SF8628, harboring the K27M mutation. Goal was to obtain quantitative estimates of K27me3 immunoprecipitation change between vehicle-treated SF8628 cells [dimethyl sulfoxide, (DMSO)] and SF8628 cells incubated with 6 mM GSKJ4 at 24 hours and 72 hours. Three-condition experiment: 72 h GSKJ4-treated cells vs. 24 h GSKJ4-treated cells vs. DMSO-treated cells. Biological replicates: 1 cell line, each with 2 technical replicates per condition.

2014-07-20 | E-GEOD-59496 | biostudies-arrayexpress

Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells

Project description:ABL cells (derivative of LNCaP) were treated with 100µM UK5099 or vehicle (control) for 72 hours, at which time total RNA was collected and analyzed using RNA-sequencing

2018-11-11 | GSE114708 | GEO

Time-series RNA-seq of decitabine-treated WT HL-60 cells

Project description:We performed stranded RNA-seq on HL-60 cells treated with decitabine for 6 hours, 72 hours and 120 hours in duplicate.

2023-01-13 | GSE222821 | GEO

RNA-seq of decitabine- and RG3039-treated WT HL-60 cells

Project description:We performed stranded RNA-seq on HL-60 cells treated with decitabine for 6 hours, 72 hours and 120 hours in duplicate.

2023-01-13 | GSE222823 | GEO